Alginate and Chitosan-Based Delivery Systems for Improving the Bioavailability and Therapeutic Efficacy of Curcumin

Anand A. Sable,Amit Kunwar,Atanu Barik
DOI: https://doi.org/10.3390/pharmaceutics16030423
IF: 6.525
2024-03-20
Pharmaceutics
Abstract:One of the major challenges in harnessing the therapeutic benefits of curcumin (an active ingredient from turmeric) is its poor bioavailability due to its short biological half-life. In this regard, nanoformulations have shown tremendous hope for improving the pharmacokinetic and therapeutic behavior of curcumin by altering its biological stability and bioavailability. Biopolymers, especially alginate and chitosan, have received special attention as excipients to prepare nanoformulations of curcumin due to their abundant availability, biocompatibility, and amicability to form different types of self-assembled structures and ease of undergoing chemical modifications. However, there are certain challenges, such as poor water solubility under physiological conditions and heterogeneity with regard to molecular weight and large-scale production of well-preserved nanostructures. Substantial advancement has been achieved towards overcoming these challenges by developing newer derivatives through a chemical modifications approach, and this has ascertained the suitability of alginate and chitosan as excipients for drug delivery systems (DDS). The present minireview briefly discusses curcumin and its limitation as a drug molecule, carbohydrates as DDS, and the recent developments related to the alginate and chitosan-based nanoformulations of curcumin. Special emphasis has been given to highlighting the impact of alginate and chitosan-based nanoformulations in improving the therapeutic efficacy and bioavailability of curcumin.
pharmacology & pharmacy
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to improve the bioavailability and therapeutic effect of curcumin. Curcumin is an active ingredient extracted from turmeric. Although it has multiple biological activities, such as antioxidant, anti - inflammatory, and anti - cancer properties, its clinical application is limited due to its poor water solubility, low stability, and fast metabolic degradation rate. Therefore, the focus of this research is to develop a delivery system based on alginate and chitosan to improve the biostability and bioavailability of curcumin, thereby enhancing its pharmacological and therapeutic behaviors. Specifically, the paper explores the following aspects: 1. **Limitations of curcumin**: It introduces the limitations of curcumin as a drug molecule, especially its low solubility in water, poor stability, and rapid metabolic degradation characteristics, which limit the success rate of its clinical application. 2. **Role of drug delivery systems (DDS)**: It discusses the role of drug delivery systems in improving problems such as chemical instability, lack of cell specificity, short circulating half - life, and rapid renal clearance of drug molecules in complex biological environments. Nanotechnology has played an important role in achieving this goal. By encapsulating drugs, it can improve their chemical and biological stabilities, promote controlled release in biological environments, and confer selectivity to targets. 3. **Advantages of alginate and chitosan as DDS materials**: It describes in detail the material advantages of alginate and chitosan, two natural polysaccharides, as drug delivery system materials, including their biocompatibility, biodegradability, and the ability to easily form different types of self - assembled structures and perform chemical modifications. 4. **Alginate - based DDS**: It specifically introduces the application of alginate - based delivery systems in curcumin delivery, including forms such as alginate hydrogels, sponges, conjugates, self - assembled micelles, edible films, emulsions, microparticles, and nanoparticles prepared by the ionic gel method. Through the above research, the paper aims to provide new strategies and methods for improving the bioavailability and therapeutic effect of curcumin.